BHUMIT P PATEL
Allopathic & Osteopathic Physicians|Family Medicine STURGIS, MI NPI 1144457722
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine MI Acerta Pharma LLC All categories
General Payments — all program years on this page
$685.12
- Category: General Payments
- Program years: PY2018–2020
- Record count: 42
- As of (CMS publication): 2026-01-23
Latest program year (PY2020): $122.79 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2020) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $122.79 | 8 |
By paying entity
Latest program year (PY2020) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $34.60 | 2 |
| Supernus Pharmaceuticals, Inc. | $25.15 | 2 |
| Mylan Specialty L.P. | $21.44 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.24 | 1 |
| Novo Nordisk AS | $12.23 | 1 |
| Allergan Inc. | $12.13 | 1 |
By program year
Records — PY2020 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 723634857 | Allergan, Inc. | $12.13 | 02/19/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 726067611 | Novartis Pharmaceuticals Corporation | $17.24 | 03/03/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 736168965 | AstraZeneca Pharmaceuticals LP | $23.52 | 02/10/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 736190761 | AstraZeneca Pharmaceuticals LP | $11.08 | 02/13/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 744606237 | Novo Nordisk Inc | $12.23 | 02/18/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 748354721 | Supernus Pharmaceuticals, Inc. | $14.11 | 01/21/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 748354723 | Supernus Pharmaceuticals, Inc. | $11.04 | 03/03/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 751387421 | Mylan Specialty L.P. | $21.44 | 01/21/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.